Celularity CELU
NASDAQ CELU
$0.80 -0.02 (-2.01%)
As of: Aug 21, 2026 · 3:59 PM EDT

Celularity (CELU) Profit After Tax (2019 - 2025)

Celularity (CELU) posted quarterly Profit After Tax of $6.0 million for Q4 2025, up 120.98% year-over-year from $2.7 million in Q4 2024, and up 146.87% quarter-over-quarter from -$12.9 million in Q3 2025.

Celularity (CELU) Profit After Tax (2019 - 2025) Analysis & Trends

Celularity (CELU) has reported Profit After Tax for 7 consecutive years, with $6.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Profit After Tax rose 120.98% year-over-year to $6.0 million; the TTM figure through Dec 2025 stood at -$51.1 million (up 30.35% YoY), while the FY2025 annual figure was -$61.3 million, down 5.9% from the prior year.
  • Profit After Tax improved to $6.0 million in Q4 2025 per CELU's latest filing, from -$12.9 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $49.9 million in Q3 2021 and bottomed at -$93.9 million in Q3 2023.
  • Historically, Profit After Tax has averaged -$18.7 million across 5 years, with a median of -$16.1 million in 2024.
  • Annual changes were most pronounced in 2022 — Profit After Tax soared 506.71% — and 2023, when it slumped 1562.7%.
  • Celularity's Profit After Tax stood at -$6.0 million in 2021, then jumped by 506.71% to $24.4 million in 2022, then plunged by 44.54% to $13.6 million in 2023, then slumped by 312.57% to -$28.8 million in 2024, then soared by 120.98% to $6.0 million in 2025.
  • Business Quant data shows CELU's Profit After Tax at $6.0 million in Q4 2025, -$12.9 million in Q3 2025, and -$24.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Celularity 20.99 Mn 14.82 Mn -3.27 Mn -24.36 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.05 Mn
Sep 30, 2025 -12.90 Mn
Jun 30, 2025 -24.52 Mn
Mar 31, 2025 -19.75 Mn
Dec 31, 2024 -28.81 Mn
Sep 30, 2024 -16.10 Mn
Jun 30, 2024 -6.49 Mn
Mar 31, 2024 -22.01 Mn
Dec 31, 2023 13.56 Mn
Sep 30, 2023 -93.88 Mn
Jun 30, 2023 -48.22 Mn
Mar 31, 2023 2.66 Mn
Dec 31, 2022 24.44 Mn
Sep 30, 2022 -5.65 Mn
Mar 31, 2022 -62.87 Mn
Dec 31, 2021 -6.01 Mn
Sep 30, 2021 49.94 Mn
Jun 30, 2021 -60.61 Mn
Mar 31, 2021 -44.40 Mn
Dec 31, 2020 3.91 Mn